Correlation Between Vericel Corp and Cns Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vericel Corp and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vericel Corp and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vericel Corp Ord and Cns Pharmaceuticals, you can compare the effects of market volatilities on Vericel Corp and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vericel Corp with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vericel Corp and Cns Pharmaceuticals.

Diversification Opportunities for Vericel Corp and Cns Pharmaceuticals

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vericel and Cns is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Vericel Corp Ord and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Vericel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vericel Corp Ord are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Vericel Corp i.e., Vericel Corp and Cns Pharmaceuticals go up and down completely randomly.

Pair Corralation between Vericel Corp and Cns Pharmaceuticals

Given the investment horizon of 90 days Vericel Corp Ord is expected to generate 0.2 times more return on investment than Cns Pharmaceuticals. However, Vericel Corp Ord is 5.08 times less risky than Cns Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  2,447  in Vericel Corp Ord on September 26, 2024 and sell it today you would earn a total of  3,284  from holding Vericel Corp Ord or generate 134.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vericel Corp Ord  vs.  Cns Pharmaceuticals

 Performance 
       Timeline  
Vericel Corp Ord 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vericel Corp Ord are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady technical and fundamental indicators, Vericel Corp disclosed solid returns over the last few months and may actually be approaching a breakup point.
Cns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Vericel Corp and Cns Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vericel Corp and Cns Pharmaceuticals

The main advantage of trading using opposite Vericel Corp and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vericel Corp position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.
The idea behind Vericel Corp Ord and Cns Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets